ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (3)
2016
-
Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor–positive, human epidermal growth factor receptor 2–negative early-stage breast cancer
European Journal of Cancer, Vol. 66, pp. 104-113
2015
-
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
Annals of Oncology, Vol. 26, Núm. 7, pp. 1280-1291
2008
-
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
Annals of Oncology, Vol. 19, Núm. 6, pp. 1090-1096